Trademark: 79260990
Status Date
Tuesday, January 14, 2020
Registration Number
5958367
Registration Date
Tuesday, January 14, 2020
Filing Date
Thursday, April 18, 2019
Published for Opposition
Tuesday, October 29, 2019
9 Recorded software for use in the clinical diagnosis, prognosis, monitoring, prediction of response to treatment and on-going evaluation, analysis and study of a cancer, tumor or equivalent medical condition
5 Pharmaceutical preparations for use in in vitro testing, for use in the clinical diagnosis, prognosis, monitoring, prediction of response to treatments and on-going evaluation, analysis and study of a cancer, tumor or equivalent medical condition; chemical preparations for medical and pharmaceutical use for use in in vitro testing, for use in the clinical diagnosis, prognosis, monitoring, prediction of response to treatments and on-going evaluation, analysis and study of a cancer, tumor or equivalent medical condition; biological reagents for medical use for providing diagnostic or identification information of biological systems; immunological reagents for medical use; biological reagents for medical diagnosis; medical diagnostic kits comprising biological markers, reagents and medical tests for diagnostic purposes, for testing biological tissue samples; biological reagents for medical research; biological reagents for medical use; biological reagents for clinical diagnosis
44 Medical analysis services, namely, analysis of tumor, cancer or equivalent medical condition; medical assistance; health care services; medical therapeutic services; medical diagnostics, diagnostics in the field of medicine; genetic and tissue analysis services for medical purposes; medical testing services for the detection, quantification, localization of proteins or cells on a section of biological tissue for the purposes of medical diagnosis, namely, analyzing the immune contexture of a tumor
42 Research, development, technical design and scientific testing services in the field of oncology; industrial analysis and research services in the field of oncology; clinical trial services for others; tests in laboratories, namely, analysis of biological mechanisms of actions, biomarkers and signatures for research in biology purposes; development of quality control testing methods for others; research, development, technical design, testing, consulting and analysis services in the field of immunology and oncology; research and development of antibodies, therapeutic products, vaccines, immunotherapy treatments and diagnostic products; research services in the field of immune repertoire analysis and the genome; design and development of software in the field of biology
Feb 12, 2022
Change Of Name/Address Rec'd From Ib
May 22, 2020
Final Decision Transaction Processed By Ib
Apr 24, 2020
Final Disposition Notice Sent To Ib
Apr 24, 2020
Final Disposition Processed
Apr 14, 2020
Final Disposition Notice Created, To Be Sent To Ib
Jan 14, 2020
Registered-Principal Register
Oct 29, 2019
Official Gazette Publication Confirmation E-Mailed
Oct 29, 2019
Published For Opposition
Oct 26, 2019
Notification Processed By Ib
Oct 9, 2019
Notification Of Possible Opposition Sent To Ib
Oct 9, 2019
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Oct 9, 2019
Notification Of Notice Of Publication E-Mailed
Sep 19, 2019
Approved For Pub - Principal Register
Sep 18, 2019
Teas/Email Correspondence Entered
Sep 18, 2019
Correspondence Received In Law Office
Sep 17, 2019
Assigned To Lie
Sep 11, 2019
Teas Response To Office Action Received
Aug 9, 2019
Refusal Processed By Ib
Jul 22, 2019
Non-Final Action Mailed - Refusal Sent To Ib
Jul 22, 2019
Refusal Processed By Mpu
Jun 30, 2019
Non-Final Action (Ib Refusal) Prepared For Review
Jun 29, 2019
Non-Final Action Written
Jun 26, 2019
Assigned To Examiner
Jun 25, 2019
Application Filing Receipt Mailed
Jun 20, 2019
New Application Office Supplied Data Entered In Tram
Jun 13, 2019
Sn Assigned For Sect 66a Appl From Ib
Trademark Alertz updated from USPTO on 2030-01-24
